Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Latest News

Verizon Delivers Another Record-Breaking Quarter with 3Q 2026 Results Driven by Strong Postpaid Phone and Account Additions

globenewswire.com
VZ

Electra Refinery Construction Remains on Budget as Workforce Doubles

globenewswire.com
ELBM

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against XTI Aerospace, Inc. (XTIA), Innventure, Inc. (INV), and York Space Systems, Inc. (YSS) Announced by Holzer & Holzer, LLC

globenewswire.com
XTIA YSS INV

Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026

globenewswire.com
TNXP

Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting

globenewswire.com
ELDN

Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis

globenewswire.com
ORKA

Gildan Completes Sale of HanesBrands Australia

globenewswire.com
GIL

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine

globenewswire.com
PLUR

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

globenewswire.com
FATE

Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026

globenewswire.com
CANF